Cryoport, Inc. (CYRX)

NASDAQ: CYRX · IEX Real-Time Price · USD
24.40
-0.84 (-3.33%)
Feb 6, 2023, 2:28 PM EST - Market open
-3.33%
Market Cap 1.20B
Revenue (ttm) 233.36M
Net Income (ttm) -295.98M
Shares Out 49.00M
EPS (ttm) -6.39
PE Ratio n/a
Forward PE 58.14
Dividend n/a
Ex-Dividend Date n/a
Volume 191,578
Open 24.73
Previous Close 25.24
Day's Range 24.35 - 25.24
52-Week Range 15.63 - 45.36
Beta 1.24
Analysts Buy
Price Target 30.60 (+25.41%)
Earnings Date Feb 23, 2023

About CYRX

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the... [Read more]

Sector Industrials
Founded 1999
Employees 900
Stock Exchange NASDAQ
Ticker Symbol CYRX
Full Company Profile

Financial Performance

In 2021, CryoPort's revenue was $222.61 million, an increase of 182.87% compared to the previous year's $78.70 million. Losses were -$283.72 million, 278.2% more than in 2020.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for CYRX stock is "Buy." The 12-month stock price forecast is $30.6, which is an increase of 25.41% from the latest price.

Price Target
$30.6
(25.41% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies

Partnership to Provide Cell and Gene Industry Integrated Solution including Cryoport's IntegriCell™ platform, and Supply Chain Services NASHVILLE, Tenn. , Jan. 18, 2023 /PRNewswire/ -- Cryoport, Inc. ...

Other symbols: SYNH
2 weeks ago - PRNewsWire

Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference

NASHVILLE, Tenn. , Dec. 20, 2022 /PRNewswire/ -- Cryoport, Inc.  (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences in...

1 month ago - PRNewsWire

CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -15.38% and 13.89%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Cryoport Reports Results for the Third Quarter 2022

Third quarter revenue of $60.5 million; nine months 2022 revenue reaches $176.9 million; Cryoport Systems' revenue up 25% year-over-year $530 million in cash and short-term investments Supporting a re...

3 months ago - PRNewsWire

Cryoport to Report Third Quarter 2022 Financial Results on November 3, 2022

NASHVILLE, Tenn. , Oct. 27, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences ind...

3 months ago - PRNewsWire

CryoPort, Inc. (CYRX) Stock Jumps 10.5%: Will It Continue to Soar?

CryoPort, Inc. (CYRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near te...

3 months ago - Zacks Investment Research

Cryoport Enters into Strategic Relationship with Takeda's BioLife Plasma Services

Cryoport plans to establish an integrated supply chain platform with BioLife Plasma Services to offer standardized cell therapy collection, processing, and storage services in United States and Europe...

5 months ago - PRNewsWire

Can CryoPort, Inc. (CYRX) Climb 36% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for CryoPort, Inc. (CYRX) points to a 36.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among a...

6 months ago - Zacks Investment Research

CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -13.33% and 0.40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Cryoport Reports Results for the Second Quarter 2022

Record revenue of $64.2 million for the quarter, up 14% as reported and 18% at constant currency (year-over-year) Supporting a record 626 global clinical trials; a net of 17 new trials added during th...

6 months ago - PRNewsWire

Cryoport to Report Second Quarter 2022 Financial Results on August 4, 2022

NASHVILLE, Tenn. , July 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences ind...

6 months ago - PRNewsWire

CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Cryoport Reports First Quarter 2022 Results

Revenue of $52.3 million Provides Full Year 2022 Revenue Guidance of $260-$265 million Expansion and advancement of robust clinical pipeline continues – now supporting a record 609 clinical trials, wi...

9 months ago - PRNewsWire

Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022

NASHVILLE, Tenn. , April 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences in...

10 months ago - PRNewsWire

Cryoport Acquires Cell&Co BioServices

Acquisition of Cell&Co BioServices, Clermont-Ferrand, France, accelerates Company's EMEA expansion plans and development of its Global Supply Chain Network NASHVILLE, Tenn. , April 18, 2022 /PRNewswir...

10 months ago - PRNewsWire

Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production

Company provides further update on financial impact of New Prague, MN fire NASHVILLE, Tenn., March 30, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader...

11 months ago - PRNewsWire

Cryoport Authorizes $100 Million Repurchase Program

Management Presenting at Upcoming Investor Conferences NASHVILLE, Tenn., March 11, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-cont...

11 months ago - PRNewsWire

New Strong Sell Stocks for March 10th

BSET, CYRX, and DIN have been added to the Zacks Rank #5 (Strong Sell) List on March 10, 2022.

Other symbols: BSETDIN
11 months ago - Zacks Investment Research

CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -780% and 2.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Cryoport Reports Fourth Quarter and Full Year 2021 Results

NASHVILLE, Tenn., Feb. 24, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...

1 year ago - PRNewsWire

Here's Why CryoPort, Inc. (CYRX) is Poised for a Turnaround After Losing 22.8% in 4 Weeks

CryoPort, Inc. (CYRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in rev...

1 year ago - Zacks Investment Research

CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022

NASHVILLE, Tenn., Feb. 15, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...

1 year ago - PRNewsWire

Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility

NASHVILLE, Tenn., Feb. 9, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indus...

1 year ago - PRNewsWire

Cryoport Reports Fire Damage at MVE's New Prague Facility

NASHVILLE, Tenn., Jan. 31, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...

1 year ago - PRNewsWire